Salem Investment Counselors Inc. Has $14.47 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Salem Investment Counselors Inc. increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 176,452 shares of the company’s stock after buying an additional 14,867 shares during the quarter. Salem Investment Counselors Inc.’s holdings in GE HealthCare Technologies were worth $14,473,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Empowered Funds LLC boosted its position in GE HealthCare Technologies by 6.1% during the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after acquiring an additional 1,665 shares during the period. Acadian Asset Management LLC acquired a new position in shares of GE HealthCare Technologies in the 1st quarter valued at about $259,000. DNB Asset Management AS increased its holdings in shares of GE HealthCare Technologies by 6.7% in the 2nd quarter. DNB Asset Management AS now owns 83,310 shares of the company’s stock valued at $6,171,000 after purchasing an additional 5,207 shares during the period. Legal & General Group Plc lifted its position in shares of GE HealthCare Technologies by 4.1% in the second quarter. Legal & General Group Plc now owns 2,708,117 shares of the company’s stock worth $200,590,000 after purchasing an additional 107,000 shares in the last quarter. Finally, Franklin Resources Inc. boosted its holdings in shares of GE HealthCare Technologies by 3.6% during the second quarter. Franklin Resources Inc. now owns 470,904 shares of the company’s stock worth $34,880,000 after purchasing an additional 16,183 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $71.65 on Tuesday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The stock’s 50-day moving average is $78.91 and its two-hundred day moving average is $78.45. The firm has a market cap of $32.69 billion, a P/E ratio of 15.71, a price-to-earnings-growth ratio of 1.53 and a beta of 1.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the prior year, the company posted $1.45 EPS. The firm’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on GEHC. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their target price for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Evercore lifted their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Morgan Stanley upped their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a report on Friday, January 9th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.